In a culmination of more than a year’s worth of dedication, enthusiasm, and innovation, today we celebrate the outstanding achievement of the University of Bath, which has been recognized as the winner of the Heart Hackathon, a global, student-run, Total Artificial Heart design competition.
At the ISMCS conference in the United States, the University of Bath emerged as the champion in the competition, with the University of Monash securing the second position and California Baptist University claiming the third spot. The American University in Cairo was recognized for presenting the most innovative idea.
Team Bath Heart distinguished themselves with an innovative solution backed by a thorough design process and solid engineering, setting them apart in this groundbreaking challenge.
Peter Lewis, Executive VP, of Corporate Development at Hydrix, who presented the Heart Hackathon trophy to the winning team, praised the remarkable efforts of all participating teams. He extended his gratitude to the organizers, mentors, sponsors, and supporters who played a crucial role in making this global initiative a resounding success.
Peter Lewis noted, “The Heart Hackathon has showcased the incredible talent and potential of young innovators in the field of cardiovascular technology, and it is a testament to the power of collaborative efforts.”
The journey starts again, as we look forward to the continued growth of the Heart Hackathon and the next generation of innovators in cardiovascular technology. The success of the University of Bath and their groundbreaking design sets the bar high for future competitions, inspiring even more outstanding ideas and solutions in the field of artificial heart development.
About the Heart Hackathon
The Heart Hackathon is the world’s first total artificial heart design competition, aimed at nurturing and inspiring the next generation of innovators in cardiovascular technology. Student-led teams from around the world have worked diligently to design, prototype, and evaluate total artificial hearts, competing on a global stage to push the boundaries of medical science and innovation. It is a testament to the power of collaboration, dedication, and the pursuit of excellence in cardiovascular technology.